Published in Stroke on January 01, 2001
Safety Study of Dabigatran in CADASIL (SONICA) | NCT01361763
Neuropathological correlates of temporal pole white matter hyperintensities in CADASIL. Stroke (2009) 1.30
Pathophysiology of the neurovascular unit: disease cause or consequence? J Cereb Blood Flow Metab (2012) 1.28
Migraine aura pathophysiology: the role of blood vessels and microembolisation. Lancet Neurol (2010) 1.15
CADASIL: experimental insights from animal models. Stroke (2010) 1.15
Hypertension and cerebral vasoreactivity: a continuous arterial spin labeling magnetic resonance imaging study. Hypertension (2010) 1.02
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy syndrome mutations increase susceptibility to spreading depression. Ann Neurol (2011) 0.90
Impaired vascular mechanotransduction in a transgenic mouse model of CADASIL arteriopathy. Stroke (2004) 0.89
Cerebral vascular dysregulation in the ischemic brain. Handb Clin Neurol (2009) 0.87
Consensus statement for diagnosis of subcortical small vessel disease. J Cereb Blood Flow Metab (2016) 0.84
Enhanced L-arginine-induced vasoreactivity suggests endothelial dysfunction in CADASIL. J Neurol (2008) 0.83
Cerebrovascular reactivity and dynamic autoregulation in nondemented patients with CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy). J Neurol (2005) 0.83
Proteome analysis of cultivated vascular smooth muscle cells from a CADASIL patient. Mol Med (2007) 0.79
Genetic animal models of cerebral vasculopathies. Prog Mol Biol Transl Sci (2012) 0.79
Microembolic signals in systemic lupus erythematosus and other cerebral small vessel diseases. J Neurol (2009) 0.77
The NOTCH3 score: a pre-clinical CADASIL biomarker in a novel human genomic NOTCH3 transgenic mouse model with early progressive vascular NOTCH3 accumulation. Acta Neuropathol Commun (2015) 0.77
The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer's Disease. Cell Mol Neurobiol (2016) 0.77
Cerebral vasoconstriction reactions and plasma levels of ETBR, ET-1, and eNOS in patients with chronic high altitude disease. Mol Med Rep (2016) 0.75
Mechanistic insights into a TIMP3-sensitive pathway constitutively engaged in the regulation of cerebral hemodynamics. Elife (2016) 0.75
CADASIL accelerated by acute hypotension: Arterial and venous contribution to leukoaraiosis. Neurology (2017) 0.75
Adaptive metabolic changes in CADASIL white matter. J Neurol (2009) 0.75
CADASIL: Treatment and Management Options. Curr Treat Options Neurol (2017) 0.75
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med (2009) 7.53
Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med (2000) 4.98
The ubiquitin pathway in Parkinson's disease. Nature (1998) 4.48
Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine. Neurology (2004) 3.43
Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology (2010) 3.31
Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication. Neurology (2007) 2.72
The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol (1998) 2.72
EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol (2011) 2.63
Long-term ambulatory gastric pH monitoring: validation of a new method and effect of H2-antagonists. Gastroenterology (1985) 2.34
Evidence-based cognitive rehabilitation: recommendations for clinical practice. Arch Phys Med Rehabil (2000) 2.33
High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am J Pathol (1999) 2.22
Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade. J Pathol (2001) 2.20
A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology (2011) 2.09
Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet (2001) 2.06
[A comparison of cholinesterase inhibitors and ginkgo extract in treatment of Alzheimer dementia]. Fortschr Med Orig (2001) 2.02
[Intercultural differences in the treatment of severely injured patients with poor prognosis. Using the example of a 23-year-old Chinese patient]. Unfallchirurg (2013) 1.98
Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc Natl Acad Sci U S A (2000) 1.97
Autosomal dominant parkinsonism associated with variable synuclein and tau pathology. Neurology (2004) 1.86
Subarachnoid hemosiderosis and superficial cortical hemosiderosis in cerebral amyloid angiopathy. AJNR Am J Neuroradiol (2007) 1.84
Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine. Br J Clin Pharmacol (2000) 1.82
High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am J Pathol (2000) 1.82
Association of an interleukin 1 alpha polymorphism with Alzheimer's disease. Neurology (2000) 1.76
Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol (2009) 1.76
Lacunar lesions are independently associated with disability and cognitive impairment in CADASIL. Neurology (2007) 1.70
The tremor network targeted by successful VIM deep brain stimulation in humans. Neurology (2012) 1.69
1H-MRS alterations in the cerebellum of patients with familial hemiplegic migraine type 1. Neurology (2005) 1.65
High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer. Cancer Res (2001) 1.64
GBA-associated PD presents with nonmotor characteristics. Neurology (2011) 1.63
Paroxysmal choreoathetosis/spasticity (DYT9) is caused by a GLUT1 defect. Neurology (2011) 1.58
Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke. J Neurol Neurosurg Psychiatry (1998) 1.55
Transformations towards the normal distribution of broad band spectral parameters of the EEG. Electroencephalogr Clin Neurophysiol (1982) 1.55
EEG coherence in Alzheimer disease. Electroencephalogr Clin Neurophysiol (1994) 1.53
EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease. Eur J Neurol (2013) 1.52
Parkin is transcriptionally regulated by ATF4: evidence for an interconnection between mitochondrial stress and ER stress. Cell Death Differ (2010) 1.52
Cervical dystonia in monozygotic twins: case report and review of the literature. Mov Disord (2001) 1.51
Induction of systemic acquired disease resistance in plants by chemicals. Annu Rev Phytopathol (1994) 1.46
Endovascularly or surgically treated vertebral artery and posterior inferior cerebellar artery aneurysms: clinical analysis and results. Zentralbl Neurochir (2005) 1.45
Slow-release sodium fluoride in the management of postmenopausal osteoporosis. A randomized controlled trial. Ann Intern Med (1994) 1.45
Prevention of interferon-stimulated gene expression using microRNA-designed hairpins. Gene Ther (2008) 1.44
Three cases of CLIPPERS: a serial clinical, laboratory and MRI follow-up study. J Neurol (2011) 1.43
Genetic assessment of familial and early-onset Parkinson's disease in a Greek population. Eur J Neurol (2013) 1.43
[FEES in the stroke unit: recommendations for implementation in the clinical routine]. Nervenarzt (2013) 1.42
[Vascular dementia]. Fortschr Neurol Psychiatr (2014) 1.41
Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer (2000) 1.41
A case of amyotrophic lateral sclerosis with a very slow progression over 44 years. Neuromuscul Disord (2001) 1.40
Functional outcome after surgical treatment of intramedullary spinal cord tumors: experience with 78 patients. Spinal Cord (2005) 1.39
Spinocerebellar ataxia type 6: evidence for a strong founder effect among German families. Neurology (1999) 1.39
Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease. Neurology (2008) 1.39
Dynamic CT perfusion imaging of acute stroke. AJNR Am J Neuroradiol (2000) 1.38
Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients. Sleep (2000) 1.37
Provider-patient communication and metabolic control. Diabetes Care (1993) 1.33
The DYT1 gene on 9q34 is responsible for most cases of early limb-onset idiopathic torsion dystonia in non-Jews. Am J Hum Genet (1994) 1.30
Differential diagnosis of CNS lesions in AIDS patients by FDG-PET. J Comput Assist Tomogr (1995) 1.26
The alpha-synuclein gene in multiple system atrophy. J Neurol Neurosurg Psychiatry (2006) 1.25
Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes. Am J Pathol (1998) 1.24
Analysis of the adolescent growth spurt using smoothing spline functions. Ann Hum Biol (1978) 1.22
A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force. Eur J Neurol (2006) 1.22
Neuronal activity of the human subthalamic nucleus in the parkinsonian and nonparkinsonian state. J Neurophysiol (2008) 1.20
The Causative Classification of Stroke system: an international reliability and optimization study. Neurology (2010) 1.19
Two common mitochondrial DNA polymorphisms are highly associated with migraine headache and cyclic vomiting syndrome. Cephalalgia (2009) 1.18
Novel mutation in the TOR1A (DYT1) gene in atypical early onset dystonia and polymorphisms in dystonia and early onset parkinsonism. Neurogenetics (2001) 1.18
Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban. Clin Res Cardiol (2013) 1.17
Variability of familial hemiplegic migraine with novel A1A2 Na+/K+-ATPase variants. Neurology (2004) 1.17
Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: evaluation of active electrode contacts. J Neurol Neurosurg Psychiatry (2003) 1.17
Small in-frame deletions and missense mutations in CADASIL: 3D models predict misfolding of Notch3 EGF-like repeat domains. Eur J Hum Genet (2000) 1.17
Height correlations between parents and mature offspring in normal subjects and in subjects with Turner's and Klinefelter's and other syndromes. Ann Hum Biol (1977) 1.15
The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA Study Group. Brain (2005) 1.14
Outcome of acute vertebrobasilar occlusions treated with intra-arterial fibrinolysis in 180 patients. AJNR Am J Neuroradiol (2006) 1.14
Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects. Am J Hum Genet (2001) 1.13
Test-retest reliability of spectral parameters of the EEG. Electroencephalogr Clin Neurophysiol (1985) 1.12
In vitro antibacterial activity of trimethoprim alone and combined with sulfonamides. Antimicrob Agents Chemother (Bethesda) (1966) 1.12
Differential lesion patterns in CADASIL and sporadic subcortical arteriosclerotic encephalopathy: MR imaging study with statistical parametric group comparison. Radiology (2001) 1.12
CDKNA2A mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas: evidence for a second tumor suppressor gene proximal to CDKN2A. Am J Pathol (2001) 1.12
Psychosocial aspects of Parkinson's disease. Neurology (1993) 1.08
Time trends in systemic thrombolysis in a large hospital-based stroke registry. Cerebrovasc Dis (2012) 1.08
Strong genetic evidence for association of TOR1A/TOR1B with idiopathic dystonia. Neurology (2006) 1.07
Deep brain stimulation in the subthalamic area is more effective than nucleus ventralis intermedius stimulation for bilateral intention tremor. Acta Neurochir (Wien) (2007) 1.06
German-Canadian family (family A) with parkinsonism, amyotrophy, and dementia - Longitudinal observations. Parkinsonism Relat Disord (1997) 1.06
The European Multiple System Atrophy-Study Group (EMSA-SG). J Neural Transm (Vienna) (2005) 1.05
Novel single-pass exchange of circulating uridine in rat liver. Science (1981) 1.05
Bilateral subthalamic stimulation in Parkin and PINK1 parkinsonism. Neurology (2008) 1.03
Serological investigations of a bovine respiratory disease ("urner pneumonie") resembling farmer's lung. Infect Immun (1972) 1.03
Noncontrast CT in deep cerebral venous thrombosis and sinus thrombosis: comparison of its diagnostic value for both entities. AJNR Am J Neuroradiol (2009) 1.02
Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat. Exp Neurol (2006) 1.00
Comparative genomic hybridization reveals frequent chromosome 13q and 4q losses in renal carcinomas with sarcomatoid transformation. J Pathol (1998) 0.99
Shape-invariant modelling of human growth. Ann Hum Biol (1981) 0.99
Quantitative MRI in CADASIL: correlation with disability and cognitive performance. Neurology (1999) 0.99
Cross-modal plasticity for sensory and motor activation patterns in blind subjects. Neuroimage (2003) 0.99
Parkin interacts with the proteasome subunit alpha4. FEBS Lett (2005) 0.99
Integrin alphavbeta3 is expressed in selected microvessels after focal cerebral ischemia. Am J Pathol (1996) 0.98
Analysis of the interrelations between frequency bands of the EEG by means of the bispectrum. A preliminary study. Electroencephalogr Clin Neurophysiol (1971) 0.97
Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. Neurology (2000) 0.97
The prevalence of primary dystonia in the general community. Neurology (2002) 0.97